Also Notable

Nathan C. Goldman; Iowa State University Press; Ames, Iowa, 374 pages; $34.95 Houston attorney Nathan Goldman intends this book as a reference for what he calls the new era in space law—an era when major treaties have atrophied and private enterprise is beginning to enter space, answering chiefly to the laws of a venture’s home nation. Goldman, who is in private practice, teaches space law at the University of Houston and Rice University. WORSE THAN THE DISEASE: Pitfalls Of Medica

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Nathan C. Goldman;
Iowa State University Press;
Ames, Iowa, 374 pages; $34.95

Houston attorney Nathan Goldman intends this book as a reference for what he calls the new era in space law—an era when major treaties have atrophied and private enterprise is beginning to enter space, answering chiefly to the laws of a venture’s home nation. Goldman, who is in private practice, teaches space law at the University of Houston and Rice University.

WORSE THAN THE DISEASE:
Pitfalls Of Medical Progress

Diana B. Dutton,
with contributions by
Thomas A. Preston and
Nancy E. Pfund;
Cambridge University Press;

New York 520 pages; $27.50 Diana Dutton, from Stanford Medical School, and her collaborators scrutinize four case studies in the public policy snarls that surround medical and scientific innovations: DES; the artificial heart; the 1976 swine flu immunization program; and developments in genetic engineering.

A BIBLIOGRAPHY OF NEUROCOMPUTING

Casimir C. Klimasaukas; MIT Press; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies